The mutation spectrum revealed by paired genome sequences from a lung cancer patientLEE, William; ZHAOSHI JIANG; HA, Connie et al.Nature (London). 2010, Vol 465, Num 7297, pp 473-477, issn 0028-0836, 5 p.Article

Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver GenesLEE, Genee Y; HAVERTY, Peter M; DAVIS, David et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 11, pp 3114-3126, issn 0008-5472, 13 p.Article

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung CancerSORIA, Jean-Charles; MARK, Zsuzsanna; HEI, Yong-Jiang et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4442-4451, issn 0732-183X, 10 p.Article

DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non―Small Cell Lung CancerWALTER, Kim; HOLCOMB, Thomas; MODRUSAN, Zora et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2360-2373, issn 1078-0432, 14 p.Article

Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF^V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway SuppressionHOEFLICH, Klaus P; HERTER, Sylvia; STERN, Howard et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 3042-3051, issn 0008-5472, 10 p.Article

Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve SurvivalHONGKUI JIN; RENHUI YANG; SCHWALL, Ralph et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7733-7740, issn 1078-0432, 8 p.Article

Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and DrozitumabSTERN, Howard M; PADILLA, Mary; WAGNER, Klaus et al.Clinical cancer research (Print). 2010, Vol 16, Num 5, pp 1587-1596, issn 1078-0432, 10 p.Article

Placenta percreta and Uterine rupture associated with prior whole body radiation therapyNORWITZ, Errol R; STERN, Howard M; GRIER, Holcombe et al.Obstetrics and gynecology (New York. 1953). 2001, Vol 98, Num 5, pp 929-931, issn 0029-7844, 2Article

Regulation of ERK3/MAPK6 expression by BRAFHOEFLICH, Klaus P; EBY, Michael T; FORREST, William F et al.International journal of oncology. 2006, Vol 29, Num 4, pp 839-849, issn 1019-6439, 11 p.Article

Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantationTRAVER, David; WINZELER, Alissa; STERN, Howard M et al.Blood. 2004, Vol 104, Num 5, pp 1298-1305, issn 0006-4971, 8 p.Article

Oncogenic BRAF is required for tumor growth and maintenance in melanoma modelsHOEFLICH, Klaus P; GRAY, Daniel C; MURRAY, Lesley J et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 999-1006, issn 0008-5472, 8 p.Article

Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer PatientsHURVITZ, Sara A; BETTING, David J; DAMARAJU, Sambasivarao et al.Clinical cancer research (Print). 2012, Vol 18, Num 12, pp 3478-3486, issn 1078-0432, 9 p.Article

Diverse somatic mutation patterns and pathway alterations in human cancersZHENGYAN KAN; JAISWAL, Bijay S; MOORHEAD, Martin et al.Nature (London). 2010, Vol 466, Num 7308, pp 869-873, issn 0028-0836, 5 p.Article

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerRUDIN, Charles M; DURINCK, Steffen; RIVERS, Celina Sanchez et al.Nature genetics. 2012, Vol 44, Num 10, pp 1111-1116, issn 1061-4036, 6 p.Article